These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24139084)

  • 41. Autoimmune encephalitis: the first observational study from Iran.
    Etemadifar M; Aghababaei A; Nouri H; Kargaran PK; Mohammadi S; Salari M
    Neurol Sci; 2022 Feb; 43(2):1239-1248. PubMed ID: 34328580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infectious causes of encephalitis and meningoencephalitis in Thailand, 2003-2005.
    Olsen SJ; Campbell AP; Supawat K; Liamsuwan S; Chotpitayasunondh T; Laptikulthum S; Viriyavejakul A; Tantirittisak T; Tunlayadechanont S; Visudtibhan A; Vasiknanonte P; Janjindamai S; Boonluksiri P; Rajborirug K; Watanaveeradej V; Khetsuriani N; Dowell SF;
    Emerg Infect Dis; 2015 Feb; 21(2):280-9. PubMed ID: 25627940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
    Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
    Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoimmune encephalitis: a case series and comprehensive review of the literature.
    Wingfield T; McHugh C; Vas A; Richardson A; Wilkins E; Bonington A; Varma A
    QJM; 2011 Nov; 104(11):921-31. PubMed ID: 21784780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical variables that help in predicting the presence of autoantibodies in patients with acute encephalitis.
    Lizcano-Meneses A; Watanabe N; von Glehn F; Barbosa R; de Albuquerque M; Yassuda C; Moraes AS; Martínez JW; Santos LMB; Cendes F
    Seizure; 2021 Aug; 90():117-122. PubMed ID: 33658153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blood and CSF anti-neuronal antibodies testing in psychotic syndromes: a retrospective analysis from a tertiary psychiatric hospital.
    Lopes J; Malaquias MJ; Freitas J; Valido R; Carneiro P; Neves E; Moreira AM; Samões R; Santos E; Correia AP
    Immunol Res; 2024 Aug; 72(4):626-635. PubMed ID: 38291273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapeutic apheresis for autoimmune encephalitis: a nationwide data collection].
    Ehrlich S; Fassbender CM; Blaes C; Finke C; Günther A; Harms L; Hoffmann F; Jahner K; Klingel R; Kraft A; Lempert T; Tesch M; Thomsen J; Topka H; Jochim J; Veauthier C; Köhler W
    Nervenarzt; 2013 Apr; 84(4):498-507. PubMed ID: 23325312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autoimmune encephalitis positive for both anti-γ-aminobutyric acid B receptor and anticollapsin response-mediator protein 5 antibodies: A case report.
    Xia J; Yin X; Zhu M; Cao J; Song X
    Medicine (Baltimore); 2018 Jan; 97(3):e9574. PubMed ID: 29504979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Practical issues in measuring autoantibodies to neuronal cell-surface antigens in autoimmune neurological disorders: 190 cases.
    Kaneko J; Kanazawa N; Tominaga N; Kaneko A; Suga H; Usui R; Ishima D; Kitamura E; Akutsu T; Yoshida K; Nishiyama K; Iizuka T
    J Neurol Sci; 2018 Jul; 390():26-32. PubMed ID: 29801900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. KCNA2 IgG autoimmunity in neuropsychiatric diseases.
    Arlt FA; Miske R; Machule ML; Broegger Christensen P; Mindorf S; Teegen B; Borowski K; Buthut M; Rößling R; Sánchez-Sendín E; van Hoof S; Cordero-Gómez C; Bünger I; Radbruch H; Kraft A; Ayzenberg I; Klausewitz J; Hansen N; Timäus C; Körtvelyessy P; Postert T; Baur-Seack K; Rost C; Brunkhorst R; Doppler K; Haigis N; Hamann G; Kunze A; Stützer A; Maschke M; Melzer N; Rosenow F; Siebenbrodt K; Stenør C; Dichgans M; Georgakis MK; Fang R; Petzold GC; Görtler M; Zerr I; Wunderlich S; Mihaljevic I; Turko P; Schmidt Ettrup M; Buchholz E; Foverskov Rasmussen H; Nasouti M; Talucci I; Maric HM; Heinemann SH; Endres M; ; Komorowski L; Prüss H
    Brain Behav Immun; 2024 Mar; 117():399-411. PubMed ID: 38309639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.
    Mariotto S; Gajofatto A; Zuliani L; Zoccarato M; Gastaldi M; Franciotta D; Cantalupo G; Piardi F; Polo A; Alberti D; Sartori S; Zanusso G; Agrò L; Demurtas R; Sechi G; Sechi E; Monaco S; Ferrari S
    J Neurol; 2019 Jul; 266(7):1643-1648. PubMed ID: 30944980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Japanese encephalitis-induced anti-N-methyl-d-aspartate receptor encephalitis: A hospital-based prospective study.
    Ma J; Han W; Jiang L
    Brain Dev; 2020 Feb; 42(2):179-184. PubMed ID: 31563418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children.
    Wright S; Hacohen Y; Jacobson L; Agrawal S; Gupta R; Philip S; Smith M; Lim M; Wassmer E; Vincent A
    Arch Dis Child; 2015 Jun; 100(6):521-6. PubMed ID: 25637141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis.
    Liu CY; Zhu J; Zheng XY; Ma C; Wang X
    Mediators Inflamm; 2017; 2017():6361479. PubMed ID: 28698711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy.
    Shin YW; Lee ST; Shin JW; Moon J; Lim JA; Byun JI; Kim TJ; Lee KJ; Kim YS; Park KI; Jung KH; Lee SK; Chu K
    J Neuroimmunol; 2013 Dec; 265(1-2):75-81. PubMed ID: 24176648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Admission diagnoses of patients later diagnosed with autoimmune encephalitis.
    Baumgartner A; Rauer S; Hottenrott T; Leypoldt F; Ufer F; Hegen H; Prüss H; Lewerenz J; Deisenhammer F; Stich O
    J Neurol; 2019 Jan; 266(1):124-132. PubMed ID: 30421340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical symptoms of patients with autoimmune encephalitis: a guide to timely recognition and treatment].
    Crijnen YS; de Vries JM; Schreurs MWJ; Titulaer MJ
    Ned Tijdschr Geneeskd; 2019 Dec; 163():. PubMed ID: 32073782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Limbic encephalitis associated with anti-NH2-terminal of α-enolase antibodies: A clinical subtype of Hashimoto encephalopathy.
    Kishitani T; Matsunaga A; Ikawa M; Hayashi K; Yamamura O; Hamano T; Watanabe O; Tanaka K; Nakamoto Y; Yoneda M
    Medicine (Baltimore); 2017 Mar; 96(10):e6181. PubMed ID: 28272206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABA
    Caputo D; Iorio R; Vigevano F; Fusco L
    Eur J Paediatr Neurol; 2018 Jan; 22(1):182-185. PubMed ID: 29203057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiparametric serological testing in autoimmune encephalitis using computer-aided immunofluorescence microscopy (CAIFM).
    Fraune J; Gerlach S; Rentzsch K; Teegen B; Lederer S; Affeldt K; Fechner K; Danckwardt M; Voigt J; Probst C; Komorowski L; Stöcker W
    Autoimmun Rev; 2016 Oct; 15(10):937-42. PubMed ID: 27490202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.